Earnings Outlook For Neurocrine Biosciences
Portfolio Pulse from Benzinga Insights
Neurocrine Biosciences (NASDAQ:NBIX) is set to release its latest quarterly earnings report on Tuesday, 2023-08-01. Analysts estimate an earnings per share (EPS) of $0.77. The company's past performance shows a pattern of share price changes following earnings reports. The company's shares were trading at $102.75 as of July 28, with a 52-week increase of 11.22%.
July 31, 2023 | 2:04 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Neurocrine Biosciences is expected to report an EPS of $0.77 in its upcoming earnings report. The company's share price has historically been affected by its earnings reports.
The upcoming earnings report is a significant event for Neurocrine Biosciences. The company's share price has historically been affected by its earnings reports, indicating a high relevance of this news. The estimated EPS of $0.77 is an important factor for investors, contributing to the importance score. The confidence score is based on the clear and direct information provided in the news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100